AI-powered search

If a patient has a family history of MS, would you treat the patient with a TNF Blocker or switch to something else?

Featuring Benjamin Lockshin, MD |

EVP of Strategic Initiatives
Director of the Clinical Trials Center
Assistant Professor
US Dermatology Partners
Georgetown University
Rockville, MD

| Published April 15, 2022

Loading...

Related Media

Powered by Polaris TM
Dermsquared

The leading solutions platform for dermatology professionals to elevate patient care.

Contact Us

Support

Subscribe now

Enter your email to get the latest updates.

© 2024 dermsquared | All Rights Reserved